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“Big data” is increasingly being used for orthopaedic research. However, the acute and 
complex nature of orthopaedic trauma makes data collection and data analysis difficult. 
This thesis presents three different clinical studies, which together illustrate how 
databases may best be used to answer clinical questions in orthopaedic trauma. 
Specifically the studies aim to show (1) how different databases capture trauma 
populations, (2) how databases may be used for hypothesis discovery studies, and (3) 
how databases may be used for hypothesis testing studies.   
Study Questions 
(1) How do populations of femoral shaft fracture patients differ in three commonly used 
national databases, specifically in regards to age and preexisting comorbidities? (2) What 
risk factors are associated with delayed surgery after elderly hip fractures in a national 
cohort and subsequently an institutional cohort? (3) Does hospital resource utilization 
differ between subpopulations of patients in Medicare Diagnosis Related Group 536 
(fractures of the hip and pelvis), despite equal Medicare hospital reimbursement? 
Methodology 
(1) Patients with surgically managed femoral shaft fractures were identified in the 
Nationwide Inpatient Sample (NIS), National Surgical Quality Improvement Program 
(NSQIP) and National Trauma Data Bank (NTDB). The distributions of age and 
Charleston Comorbidity Index were compared between populations. (2) A retrospective 
cohort study was conducted of all elderly hip fracture patients receiving surgical 
management from 2011-2012 in the NTDB and from 2009-2015 at a single academic 
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trauma center. Multivariate analysis was used to identify the independent effect of 
various risk factors on surgical timing. (3) Patients with hip fractures, non-operative 
pelvic fractures, acetabulum fractures, and operative pelvic fractures were identified in 
the 2011 – 2012 NTDB. Total inpatient length of stay, intensive care unit (ICU) stay, and 
ventilator time were compared across groups using multivariate analysis that controlled 
for patient and hospital factors. 
Results 
(1) A predominantly older population with more preexisting comorbidities was found in 
NSQIP (age = 71.5, CCI = 4.9), while a substantially younger population with fewer 
preexisting comorbidities was fond in NTDB (age = 45.2, CCI = 2.1). Bimodal 
distributions in the NIS population indicate a more mixed population (age = 56.9, CCI = 
3.2). Differences in age were all statistically significant (p < 0.001). (2) In the national 
cohort, mean time to surgery was 31.3 hours (standard deviation: 31.6 hours). The risk 
factors with largest association with delays were total arthroplasty surgery (coefficient, in 
hours [95% confidence interval]: 7.7 [6.1 – 9.3]) coagulopathy, including chronic 
anticoagulation (7.1 [6.1 – 8.0]), and congestive heart failure (6.9 [6.0 – 7.9]). In the 
institutional cohort, mean time to surgery was 32.4 hours (standard deviation: 29.0 
hours). In this cohort, the only statistically significant risk factors associated with surgical 
timing were total arthroplasty surgery (24.5 [13.7 – 35.4]), transfer from outside hospital 
(22.1 [15.1 – 29.1]), warfarin anticoagulation (13.7 [8.5 – 18.8]), other anticoagulation 
(10.5 [2.4 – 18.5]), and preoperative hematocrit < 35% (5.5 [2.0 – 9.0]). (3) After 
controlling for patient and hospital factors, the difference in inpatient length of stay 
compared to hip fracture patients was -0.2 days (95% C.I.: -0.4 to -0.1 days; P = 0.001) 
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for non-operative pelvis fractures, 1.7 days (95% C.I.: 1.4 to 1.9 days; P < 0.001) for 
acetabulum fractures, and 7.7 days (95% C.I.: 7.0 to 8.4 days; P < 0.001) for operative 
pelvic fractures. Similar differences were also noted for IVU stay and ventilator time.  
Conclusion 
(1) While these three national databases have been commonly used for orthopaedic 
trauma research, differences in the populations they contain are not always readily 
apparent. Care must be taken to fully understand these populations before performing or 
evaluating database research, as these differences clearly affect observed outcomes. (2) 
Of all risk factors identified, access to arthroplasty and management of chronic 
anticoagulation may be the most modifiable in order to reduce delayed hip fracture 
surgeries. Physician call coverage and algorithms for more rapid reversal of 
anticoagulation, namely warfarin anticoagulation, warrant further investigation.  
 (3) Because hospitals are reimbursed equally for these subgroups of Medicare DRG 536, 
those centers that care for a greater proportion of more-complex pelvic trauma will 
experience lower financial margins per trauma patient, limiting their potential for growth 
and investment compared with competing institutions that may not routinely see high-
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Introduction to Thesis 
 The use of large national databases in orthopaedic research has grown 
substantially over the last 10 years.1  While the randomized controlled trial (RCT) 
remains the gold standard for answering clinical questions, RCTs are often unfeasible, 
especially in orthopaedic settings. An adequately powered trial requires a large number of 
patients, often from multiple centers, with the logistics of this making RCTs very costly. 
The large Spine Patients Outcomes Research Trial (SPORT) was estimated to cost $30 
million,1, 2 while the smaller Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST) 
cost $7 million.1  
In addition blinding to placebo or “sham surgery” treatments may be unethical in 
many cases, while this blinding has also proven to be essential to avoid bias based on 
patient expectations. For example Moseley et al found that after randomizing 180 patients 
to arthroscopic knee debridement, lavage, or sham surgery that patient reported outcomes 
were no different between groups.3 Furthermore, when surgical treatment is not blinded 
there remains the potential for substantial cross over from placebo to treatment groups, as 
was seen in the SPORT trial with conservatively managed patients eventually wanting 
surgical treatment for non-resolving symptoms.4  
 As these issues make RCTs impractical in many cases, the observational cohort 
study has come to be the standard for clinical research in orthopaedic surgery. Indeed, a 
well-designed observational study, carefully controlling for potential sources of bias, may 
provide a strong level of evidence, which approaches that of an RCT. For example in the 
SPORT trial, while intention-to-treat data was found to be inconclusive due to high rates 
of cross-over,4 a secondary observational study of the data based on per protocol analysis 
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and carefully controlling for sources of bias, did demonstrate benefits with surgical 
treatment of herniated lumbar discs.5  
 Large national databases provide a unique platform for observational clinical 
studies providing large patient populations suitable for studying rare procedures, 
populations, and outcomes that would otherwise be difficult to study by a single provider, 
institution, or even group of institutions.1, 6 As data collection is done preemptively, these 
studies can be completed at low cost, and with careful study design, several of the 
inherent biases of retrospective studies can be controlled for. The lack of orthopaedic-
specific data elements in many of the presently general surgery-focused national 
databases does limit the ability to measure orthopaedic outcomes of interest, such as 
functionality measures, and control for factors that influence orthopaedic outcomes, such 
as implant use or fracture classification. Nevertheless, the wealth of data available in 
these national datasets has already allowed several impactful studies to be completed.7-13 
 Clinical studies utilizing “big data” in orthopaedic surgery can be classified into 
two broad categories: hypothesis-finding and hypothesis-testing studies. Hypothesis-
finding studies leverage the large patient populations and numerous data elements 
contains in databases to identify risk factors associated with surgical outcomes. For 
example Basques et al. identified several risk factors for blood transfusion in over 4,000 
patients undergoing primary posterior lumbar fusion, including a greater number of levels 
fused, longer operative time, and preoperative anemia.14 This type of study opens the 
door for further investigation of targeted interventions that may prevent blood 
transfusions in this population. It also provides risk stratification information to providers 
for both patient counseling and surgical planning purposes. In contrast, hypothesis-testing 
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studies aim to answer a narrowly defined questions using statistical testing controlling for 
other confounding factors. For example, Bohl et al determined that patients receiving 
intramedullary implants for intertrochanteric hip fractures had a shorter postoperative 
lengths of stay compared with those receiving extramedullary implants.7 This type of 
study adds to the body of literature that may favor one method of treatment versus 
another, impacting clinical standards of care. In orthopaedic surgery, both hypothesis-
finding and hypothesis-testing studies have utility in answering clinical questions and 
directing practice.  
 While many orthopaedic questions have been answered using “big data,” one 
population that remains difficult to study are orthopaedic trauma populations. In the acute 
trauma setting, careful data collection is often difficult when urgent test and interventions 
are necessary. In addition there is considerable variability in injury patterns and 
associated injuries among fracture patients, all of which may not be well captured in 
databases but do still impact clinical management and patient outcomes. Nevertheless, 
“big data” has already been used extensively to study orthopaedic trauma populations. 
Therefore, it is important to identify effective methods for conducting clinical research on 
orthopaedic fracture populations, using large national databases. 
 The current work aims to address this goal in three sections, each an individual 
completed clinical study, either published or submitted for publication, illustrating a 
different aspect of research design. In Section I, entitled “Do we really know our patient 
population in database research: A comparison of the femoral shaft fracture patient 
populations in three commonly used national databases,” the high-energy femoral shaft 
fracture populations in three databases are compared. By doing this, the importance of 
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selection of an appropriate database for studying high-energy trauma populations is 
highlighted.  
In Section II, entitled “Using a National Database and Subsequently an 
Institutional Cohort to Identify Potentially Modifiable Risk Factors for Delayed Hip 
Fracture Surgery: An example of using databases for hypothesis discovery,” an example 
of a hypothesis-finding study is presented as risk factors for delayed surgery after elderly 
hip fractures are analyzed. In addition, these risk factors are further explored using a local 
institutional cohort of hip fracture patients to identify modifiable factors that may 
expedite surgery after hip fractures locally. In this way the utility of hypothesis finding 
for further investigative efforts is highlighted.  
Finally in Section III, entitled “Variation in Resource Utilization for Hip and 
Pelvic Fracture Patients, Despite Equal Medicare Reimbursement,” the specifically 
defined hypothesis of whether subgroups of patients in Medicare Diagnosis Related 
Group (DRG) 536 (fractures of the hip and pelvis) have different amounts of hospital 
resource utilization, is tested. Larger health policy implications of the findings are then 
discussed, illustrating the potential power of large well-powered databases studies for 
identifying clinically significant trends. Together the aim of the current thesis is to 
illustrate the utility of thoughtfully designed clinical research using “big data” to study 
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The use of national databases for clinical research has increased dramatically in 
the field of orthopaedic surgery over the past 5 years (Figure 1). Examples of databases 
currently being used in orthopaedic research include the Nationwide Inpatient Sample 
(NIS),15, the American College of Surgeons National Surgical Quality Improvement 
Program database (NSQIP),16 and the American College of Surgeons National Trauma 
Data Bank Research Data Set (NTDB RDS).17 Use of these databases can expedite 
clinical research and allows study of rare injury patterns using large cohorts, not possible 
for the individual researcher or even individual institution.  However with increased use 
of these databases, it is critical to understand how the database populations differ, and 
how patients are included and excluded from each, before conclusions can be made and 




Figure 1: Database studies published in orthopaedic surgery journals have increased since the year 2000. 
Studies utilizing the Nationwide Inpatient Sample (NIS), the National Surgical Quality Improvement 
Program (NSQIP), or the National Trauma Data Bank (NTDB) were identified from a PubMed search of 
the top 41 orthopaedic journals as defined by Moverly, et al.1 Publications in 2014 include only journals 
published (electronically or in print) by September 9, 2014. 
 
 Previous comparisons of databases have focused on differences in quality of 
various data elements, namely patient comorbidities and adverse events, in similar patient 
populations. These studies of patients undergoing lumbar vertebral fusions,18 hip fracture 
fixation,19 pancreaticoduodenectomy,20 and esophageal resection21 identified considerable 
differences in the recording of comorbidities and adverse events between 
administratively-coded databases, such as NIS, and registry databases, such as NSQIP. 
These studies, however, focused on patient populations that were largely similar in terms 
of basic demographics between databases. 
Regarding high-energy orthopaedic trauma, various databases may differ in what 
patients are included due to varying inclusion criteria. However of the databases cited 
above, all three have been used extensively for orthopaedic trauma research,7, 22-30 with 
little prior discussion of how the populations may actually compare to the true general 
population of orthopaedic trauma patients. As orthopaedic trauma is an area where 
database research may provide particular insights, it is critical to understand the various 
differences between orthopaedic trauma populations in various national databases. The 
current retrospective cohort study aims to determine (1) how the populations of patients 
with femoral shaft fractures, a common high-energy injury, differ in these three 
commonly used national databases, specifically in regards to age and preexisting 
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comorbidities, and (2) how these differences may affect studies of in-hospital adverse 
events observed in each population. 
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Patients and Methods 
Study design and setting 
A retrospective cohort study was performed using NIS, NSQIP, and NTDB RDS. 
For NSQIP and NTDB, data from 2011 and 2012 were used. Only 2011 data were used 
for NIS, as 2012 data were not available at the time of study. The study was approved by 
the local institutional human investigations committee. 
 
Participants/study subjects 
ICD-9 procedure codes were used to identify patients undergoing surgical 
treatment of femoral shaft fractures in NIS and NTDB (ICD-9 79.05, 79.15, 79.25, 
79.35). Current Procedural Terminology (CPT) codes were used to identify the same 
population in NSQIP (CPT 27500, 27502, 27506, 27507). Differing methods for the 
identification of patients were necessary due to differing the data elements within each 
database. 
 
Variables, outcome measures, data sources, and bias 
 Patient age, comorbidities, and adverse events were analyzed. Within all three 
databases, binary variables were used to assess comorbidities. Seven comorbidities with 
equivalent definitions across the three databases were analyzed: alcoholism, 
coagulopathy, diabetes mellitus, cancer, hypertension, obesity, and current smoker status. 
Appendix 1 lists specific data elements used to identify comorbidities in each database. 
A modified Charlson comorbidity index (CCI) was then calculated using the seven 
comorbidities analyzed and patient age. Similar to the original index,31  the modified CCI 
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assigns one point for each comorbidity diagnosis (except for disseminated cancer, as in 
original CCI six points are assigned due to poor life expectancy). One point was then 
added for each decade greater than 40 years of age. A modified CCI has been shown to 
have comparable predictive value to the original CCI,32 and has been used previously 
with national databases such as NSQIP.8   
 Adverse events were assessed using binary variables in NTDB and NSQIP and 
ICD-9 diagnosis codes in NIS. As NSQIP contains data on adverse events occurring up to 
30 days postoperatively, while NTDB and NIS contain only inpatient data, adverse events 
occurring after discharge in NSQIP were excluded. Nine adverse events with equivalent 
definitions across databases were analyzed: acute kidney injury (AKI), cardiac arrest, 
cerebrovascular accident (CVA), death, deep vein thrombosis or pulmonary embolism 
(DVT/PE), myocardial infarction (MI), pneumonia, surgical site infection (SSI), and 
urinary tract infection (UTI). Mortality rate, serious adverse event (SAE) rate (death, 
cardiac arrest, MI, CVA, DVT/PE, and SSI), and all adverse event (AAE) rate were 
computed. Appendix 2 lists specific data elements used to identify adverse events in each 
database. 
 
Statistical analysis, study size 
Several different analyses were conducted in this study. First, age was compared 
between populations. Mean age was compared using analysis of variance (ANOVA) and 
age was plotted on a histogram. CCI was similarly compared between populations. Mean 
CCI was compared using ANOVA and CCI was plotted on a histogram. 
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 Next, comorbidities were compared between databases. Rates of each of the seven 
comorbidities analyzed were compared between databases using Pearson’s chi squared 
statistic. The relative risk of each comorbidity was then estimated for both NSQIP and 
NTDB compared to NIS as a reference, and then NSQIP compared to NTDB as a 
reference. This was done using Poisson regression with robust error variance using an 
indicator variable to designate the database. As Poisson regression overestimates the error 
for relative risk when using binomial data, robust error variance was used to directly 
estimate the error for the relative risk. NIS was chosen as the denominator for both 
comparisons as this is thought to be the most nationally representative patient population.  
 Concerning adverse events, rates of mortality, serious adverse events (SAE), and 
any adverse event (AAE), were computed for each population. Pearson’s chi square 
statistic was used to compare rates between populations. Multivariate ANOVA was then 
used to compare the rates after adjusting for age and CCI.  
 Finally, a simulated theoretical analysis of risk factors associated with inpatient 
adverse events was conducted for each database population. Multivariate logistic 
regression was used to determine the association of the age and the seven individual 
comorbidities previously studied with the rate of AAEs.  
 All statistical analyses were performed using Stata® version 13.0 (StataCorp, LP, 
College Station, Texas, USA). All statistical tests were two-tailed, and the level of 




 A total of 25,121patients undergoing surgical repair of a femoral shaft fracture 
were identified and included in this study. There were 3,943 patients identified and 
included within NIS (2011 only, 2012 data was not available at time of study), 663 
patients identified and included within NSQIP (2011-2012), and 20,515 identified and 
included within NTDB (2011-2012). 
  The mean age of patients in NIS was 56.9 years (standard deviation [SD]: 24.9 
years). The mean age of patients in NSQIP was 71.5 years (SD: 15.6 years). The mean 
age of patients in NTDB was 45.2 (SD: 21.4 years). Differences in mean age between 
databases were statistically significant (p < 0.001). Both NSQIP and NTDB round ages 
greater than 90 to a value of 90 to prevent breach of privacy. The distribution of ages is 
markedly different between NSQIP (primarily older patients) and NTDB (primarily 
younger patients), with the bimodal distribution in NIS seemingly representing a more 
mixed population (Figure 2). 
The mean CCI of patients in NIS was 3.2 (SD: 2.3). The mean CCI of patients in 
NSQIP was 4.9 (SD: 1.9). The mean CCI of patients in NTDB was 2.1 (SD: 2.0). 
Differences in mean CCI between databases were statistically significant (p < 0.001). 
Similar to age, the distribution of CCI is markedly different between patients in NSQIP 
(more comorbidities) and NTDB (primarily fewer comorbidities), with NIS seemingly 
representing a more mixed population with a bimodal distribution (Figure 3).  
Rates of all individual comorbidities were greatest in the NSQIP population, 
except for alcoholism and current smoker status, which were greatest in the NTDB 
population (Figure 4). Incidence rates in the NIS population were in between the 
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incidence rates in the NTDB and NSQIP populations for all seven comorbidities. The 
relative risks of each comorbidity in the NSQIP population was statistically significant 
when compared to NIS as a standard (p < 0.05), except for diabetes (p = 0.173) and 
current smoker status (p = 0.184). The relative risks of all comorbidities in the NTDB 
population were statistically significant when compared to NIS as a standard (p < 0.05). 
 
Figure 2: Age of femoral shaft fracture patients vary by database. Histograms are of age distributions 
within the Nationwide Inpatient Sample (NIS), the National Surgical Quality Improvement Program 
(NSQIP), and the National Trauma Data Bank (NTDB). Note that NSQIP and NTDB truncate ages greater 
than 90 to age = 90. 
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Figure 3: Charlson Comorbidity Index of femoral shaft fracture patients vary by database. Histograms are 
of CCI distributions within NIS, NSQIP, and NTDB. 
 
Figure 4: The rates of individual comorbidities vary by database. On left are bar graphs of incidence rates 
in the NIS, NSQIP, and NTDB populations. On right are bar graphs of relative risks (computed using 
Poisson regression with robust error variance) of comorbidities in NSQIP and NTDB compared to NIS as a 
reference. Asterisks (*) indicate statistically significant relative risks. Error bars represent 95% confidence 
interval of relative risks.   
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The differences in mortality rate between the different databases (range 1.1% 
[NIS] to 2.0% [NSQIP]; Figure 5) were not statistically significant before risk adjustment 
(P = 0.059), however after adjusting for age and CCI the differences became significant 
(P < 0.001). The differences in SAE rate between the different databases (range 5.1% 
[NIS] to 7.4% [NTDB]) were statistically significant before and after risk adjustment (P 
< 0.001, P < 0.001). The differences in AAE rate between the different databases (range 
9.1 [NSQIP] to 21.6% [NIS]) were statistically significant before and after risk 
adjustment (P < 0.001, P < 0.001).  
  
Figure 5: Adverse event rates in femoral shaft fracture patients vary by database. Bar graphs indicate 
incidence rates of mortality, serious adverse events, and all adverse events in the NIS, NSQIP, and NTDB 
populations. The p-values are given for Pearson’s Chi Square statistic for the distribution of adverse events 
amongst databases. Statistically significant findings (p < 0.05) are indicated by asterisks and boldface. 
 
In the simulated theoretical analysis there were several differences in the 
identified risk factors for inpatient adverse events (Table 1). In the NIS population older 
age was associated with increased AAEs (odds ratio [95% confidence interval]: 4.12 
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[2.82 - 6.01]), while younger age was associated with decreased AAEs (0.57 [0.39 - 
0.84]). Old age is similarly associated with increased AAEs in the NSQIP population 
(5.56 [1.13 – 27.42]). However, in the NTDB population, older age (in the 60-69, 70-79, 
and 80+ age groups) is associated with fewer AAEs (0.78 [0.65 – 0.92]). Similarly, 
diabetes is associated with more AAEs in the NIS population (1.40 [1.14 – 1.72]) and in 
the NTDB population (1.41 [1.23 – 1.61]), and with fewer AAEs in the NSQIP 
population (0.41 [0.18 – 0.95]). Additionally, for 4 of the 6 additional comorbidities 
studied (alcoholism, smoking, obesity, and disseminated cancer), there was a change in 
the statistical significance of the association with AAEs. 
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Table 1: Theoretical analysis of risk factors associated with inpatient adverse events after 
femoral shaft fractures in three commonly used national clinical databases 
  NIS (n = 3,951) NSQIP (n = 663) NTDB (n = 20,501) 
  















      
 Alcoholism 1.22 (0.84 - 1.77) 0.296 0.00 (omitted)* - 1.39 (1.23 - 1.57) < 0001 
Smoking 0.60 (0.44 - 0.81) 0.001 1.68 (0.77 - 3.69) 0.196 0.86 (0.77 - 0.96) 0.010 
Diabetes 1.40 (1.14 - 1.72) 0.001 0.41 (0.18 - 0.95) 0.038 1.41 (1.23 - 1.61) < 0001 
Hypertension 1.04 (0.86 - 1.26) 0.699 1.54 (0.82 - 2.89) 0.182 1.06 (0.95 - 1.19) 0.300 
Bleeding 1.87 (1.41 - 2.48) < 0.001 2.06 (1.03 - 4.12) 0.041 1.94 (1.62 - 2.31) < 0001 
Obesity 1.63 (1.25 - 2.14) < 0.001 1.15 (0.60 - 2.19) 0.676 1.62 (1.41 - 1.87) < 0001 




      
 Age   
 
      
 18 - 29 0.57 (0.39 - 0.84) 0.005 0.00 (omitted)* - 0.69 (0.60 - 0.79) < 0001 
30 - 39 0.86 (0.56 - 1.31) 0.477 0.00 (omitted)* - 0.86 (0.73 - 1.00) 0.051 
40 - 49 1.26 (0.82 - 1.92) 0.29 2.52 (0.33 - 19.38) 0.374 1.04 (0.89 - 1.22) 0.581 
50 - 59 Reference 
 
Reference - Reference - 
60 - 69 1.38 (0.96 - 2.00) 0.086 3.53 (0.74 - 16.81) 0.113 0.72 (0.61 - 0.85) < 0001 
70 - 79 1.53 (1.07 - 2.18) 0.019 4.81 (1.06 - 21.74) 0.041 0.66 (0.55 - 0.79) < 0001 
80 - 89 2.84 (2.02 - 3.99) < 0.001 3.82 (0.81 - 17.92) 0.09 0.78 (0.65 - 0.92) 0.004 
90 + 4.12 (2.82 - 6.01) < 0.001 5.56 (1.13 - 27.42) 0.035 - - 
              
Note: NIS = Nationwide Inpatient Sample, NSQIP = National Surgical Quality Improvement Program, NTDB 
= National Trauma Data Bank 
*Categories were omitted from NSQIP analysis that perfectly predicted absence of adverse events 
in multivariate analysis 
 Light shading indicates statistically significant odds ratio with positive association with inpatient adverse 
events  







 The field of orthopaedic surgery has seen increased use of large national 
databases for clinical research recently. Over the past three years there has been over a 
200% increase in peer-reviewed publications utilizing NIS, NSQIP, and NTDB, in 
orthopaedic journals alone (Figure 1). In the field of orthopaedic trauma, national 
database use has increased as well, likely due to increased use of trauma-specific 
databases such as NTDB. However, as the current study indicates, various commonly 
used national clinical databases treat trauma patients very differently, and the resulting 
differences in database populations lead to significant differences in observed outcomes. 
 After comparing all patients with surgically treated femoral shaft fractures in NIS, 
NSQIP, and NTDB, the current study found that the NSQIP and NTDB populations are 
strikingly different, when considering age and comorbidities. The NTDB population is 
younger and has fewer preexisting comorbidities, while the NSQIP population is older 
and has more preexisting comorbidities. The NIS population appears to be bimodal in 
terms of age and comorbidities. While previous database comparisons have primarily 
focused on differences in specific data elements among demographically similar 
populations,19-21 the current study is the first to highlight the significant demographic 
differences of trauma populations in national databases that are each commonly used for 
orthopaedic trauma research. 
 As expected, the observed differences in populations also lead to differences in 
outcomes. There were statistically significant differences in the rates of mortality, SAEs, 
and AAEs between the three database populations, after controlling for age and CCI. 
Interestingly mortality was not significantly different between populations, likely due to 
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the low overall mortality rate among femoral shaft fracture patients (ranging from 1.1 - 
2.0%). In our theoretical study of risk factors for inpatient adverse events, there were 
several differences in the simulated results. Most striking was the change in directionality 
of the association of certain risk factors (diabetes, older age) with adverse events, 
depending on the database studied. This illustrates the importance of understanding the 
database population being studied before attempting to generalize results of a study to 
other clinical populations.  
The differences in database populations demonstrated in the current study 
highlight the relative strengths and weakness of each database (Table 2). Based on 
sampling methodology, NIS is the most nationally representative and comprehensive 
sample. NSQIP and NTDB include only data from voluntarily participating institutions, 
and are likely biased towards larger hospitals that have interests in quality monitoring and 
improvement. In contrast the Hospital Cost and Utilization Project takes data from all 
inpatient discharges from a nationally representative sample of community hospitals 
(approximately 20% of all U.S. community hospitals). While this is a relative strength of 
the NIS dataset, the quality of the billing code data it contains has previously been called 
into question.33-35 NIS contains strictly ICD-9 billing code diagnoses compared to NSQIP 
and NTDB, which utilize chart-abstracted diagnoses for comorbidities and adverse 
events. ICD-9 coding inconsistencies have been noted in past studies comparing 
databases with administratively-coded versus chart-abstracted data. 19, 33-36 As 
administrative billing codes are subject to economic and political pressures, there is 
potential for underreporting or over-reporting certain diagnoses. 
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adverse event definitions. 
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 The ACS NSQIP is primarily geared towards elective surgery, with some 
institutions only reporting elective general surgery and vascular surgery cases. Most acute 
trauma and transplant procedures are excluded. Review of NSQIP data collection 
guidelines for surgical clinical reviewers indicates that most high energy mechanisms of 
injury are excluded from the database, such as motor vehicle accidents and firearms.37 
Lower energy mechanisms that are included consist of falls from standing or from up to 3 
steps resulting in non-penetrating, single-bone or single organ system injury.37 Therefore, 
the fracture population contained in NSQIP likely consists largely of patients with 
preexisting comorbidities such as osteoporosis, preexisting prostheses, prior fractures or 
nonunions, or bony metastasis, all resulting in weaker bone stock and higher likelihood of 
fracture with lower energy mechanisms. Nevertheless, despite NSQIP including only a 
small subset of all fractures, studies have been published utilizing NSQIP to draw 
conclusions regarding orthopaedic trauma patient populations.19, 28-30 While NSQIP does 
have the most reliable data collection system, including specially trained NSQIP surgical 
clinical reviewers and regular inter-rater reliability audits; trauma researchers should 
carefully consider whether NSQIP truly captures the intended population before using the 
database for clinical studies.  
In contrast, NTDB likely contains the best representation of the acute high-energy 
fracture patient population. All patients admitted through the emergency department at 
participating institutions with a trauma-specific ICD-9 diagnosis code (800.0 – 959.9) 
meet NTDB inclusion criteria.17 However, these criteria do not include pathologic 
fractures (ICD-9 733.1X), stress fractures (733.9X), or fracture nonunions and malunions 
(733.8X). These reasons help explain why the population of surgically treated femoral 
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shaft fracture patients in NTDB is primarily younger patients, likely with higher-energy 
mechanisms of injury.  
No database serves as a “gold standard” for study of trauma populations. Rather, 
study of each of these individual trauma populations does have merit. Femoral shaft 
fractures represent a spectrum of injuries resulting from both low-energy and high-energy 
mechanisms, as demonstrated by the bimodal age distribution seen in NIS. As a true 
national sampling of inpatients, NIS would be ideal for national-level demographic and 
incidence studies of all types of femoral shaft fracture patients. Studies intending to focus 
on osteoporotic type stress fractures would be well suited to the NSQIP population. On 
the other hand, NTDB is skewed toward younger, high-energy patients seen at Level I 
and II, and is best suited for study of this unique population. 17  
Furthermore, each of the databases offers unique data elements that allow for 
differing study opportunities. NSQIP has several unique intraoperative variables (i.e. 
operative time, anesthesia type, intraoperative transfusion) in addition to documentation 
of adverse events that occur up to 30 days after surgery (often after discharge). NTDB 
contains detailed pre-hospital variables, such as ambulance time and mechanism of 
injury, and emergency department variable. NIS, in contrast, largely contains only data 
derived from ICD-9 billing codes, but is useful due to its nationally weighted sampling 
from all U.S. inpatient admissions.  
The primary limitation of this study is the lack of hospital specific identifiers that 
could be matched between databases.  This would allow comparison of the patient 
samples obtained from the same institutions. However, in order to maintain anonymity of 
the participating institutions, these data are not present in any of the three databases. 
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While it is impossible to tell whether differences in populations are due to differences in 
the institutions included versus differences in how trauma patients are included within 
individual institutions, the differences observed are still significant and warrant careful 
consideration for future studies. 
When planning database studies, careful consideration must be made to ensure 
researchers and those evaluating database research fully understand the populations being 
studied. Due to large sample sizes, statistically significant results may be drawn from 
each database. Therefore appreciation of population demographics and database inclusion 
criteria is imperative to ensure that the conclusions drawn are indeed valid and are 
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There is considerable evidence associating earlier surgery after elderly hip 
fracture with reduced mortality 38-45, shorter length of stay 39, 44, 46, improved discharge 
disposition 44, 47, and fewer complications 48. Currently, both in the United States and 
United Kingdom, national orthopaedic practice guidelines support early operative 
management and mobilization of these patients. In 2010, the England and Wales 
Department of Health instituted a Best Practice Tariff providing financial incentives for 
hospital to follow a specified care pathway for patients with hip fractures, including 
surgery within 36 hours of admission 49, 50. In 2014 the American Academy of 
Orthopaedic Surgeons (AAOS) released a Clinical Practice Guideline, entitled 
Management of Hip Fractures in the Elderly, recommending surgery within 48 hours of 
admission for all elderly hip fracture patients 51. In addition, a recent Danish cohort study 
demonstrated that surgical delay past 12 hours was associated with increased rates of 30-
day mortality 52. With the Canadian Hip Fracture Accelerated Surgical Treatment And 
Care Track Trial (HIP ATTACK) now ongoing 53, examining potential benefits of 
accelerated surgery within 6 hours, it is possible that clinical evidence and national 
bodies will further support even earlier surgical intervention in these patients.  
With the growing literature supporting early and accelerated surgical management 
of elderly hip fractures, there is a need to identify means to reduce our current 
preoperative time in the most efficient means possible. A recent cohort study of 2 million 
patients in the National Inpatient Survey (NIS) database identified risk factors for delayed 
surgery: race, Medicaid insurance, Northeastern hospital location, and higher comorbidity 
scores were associated with delayed surgical management 54. However, these factors are 
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large non-modifiable. In addition, the authors did not comment on the marginal effect of 
various risk factors on overall surgical timing. The current analysis first utilizes a large 
national cohort to identify medical comorbidities that may predispose patients to surgical. 
Next, based on the results from the national cohort, a more focused analysis of more 
modifiable risk factor was conducted using a cohort from a single academic trauma 
center. The authors of the present study also hope to present a new paradigm for clinical 
research using national databases, utilizing a national cohort first to better focus the 
analysis of a local cohort. 
The objectives of this study are to answer the following: (1) What risk factors are 
associated with delays to surgery in a national cohort? (2) What modifiable risk factors 
are associated with delays to surgery within in our institutional cohort? 
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Patients and Methods 
Study Design and Setting 
Two separate populations were studies. First a retrospective cohort study was 
conducted using the 2011-2012 American College of Surgeons (ACS) National Trauma 
Data Bank (NTDB). NTDB is the largest national database of trauma cases, including 
cases from over 900 voluntarily participating trauma centers across the United States17. 
Next, a retrospective cohort study was conduct at a single academic trauma center located 
in an urban setting.  
 
Participants/Study Subjects 
In both the national and institutional cohorts patients were identified using 
International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes All 
patients aged 65 years or greater with femoral neck fractures (820.0X, 820.1X), 
intertrochanteric fractures (820.2X, 820.3X), or unspecified hip fractures (820.8, 820.9) 
were included in the study. The NTDB cohort included patients from admission years 
2011 and 2012, while the institutional cohort included patients from admission years 
2009 to 2015. The following ICD-9 procedure codes were then used to identify patients 
that underwent surgical fixation: 79.15 (closed reduction and internal fixation of the 
femur), 79.35 (open reduction and internal fixation of the femur), 81.52 
(hemiarthroplasty of the hip), 81.51 (total arthroplasty of the hip), and 81.40 (repair of 
hip, not elsewhere classified).  
All patients without ICD-9 codes for surgical fixation or with missing data 
regarding time to surgical fixation were excluded. Furthermore, as the NTDB contains a 
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disproportionate number of high-energy trauma patients from level-one trauma centers, 
only patients with Injury Severity Score < 9 were included in this population, to best 
represent the population of patients suffering typical elderly fragility fractures of the hip. 
An Injury Severity Score of 9 corresponds with a single, isolated hip fracture.  
 
Description of experiment, treatment, or surgery 
All patients underwent surgical treatment of their hip fracture during initial 
hospital admission in both cohorts. Patient were categorized based on the type of surgical 
procedures:  closed reduction and internal fixation of the femur (CRIF), open reduction 
and internal fixation of the femur (ORIF), hemiarthroplasty of the hip, total arthroplasty 
of the hip, and repair of the hip not elsewhere classified. 
 
Variables, outcome measures, data sources, and bias 
 In the national cohort, the following risk factors for delayed surgery were 
analyzed: gender, age, coagulopathy (including anticoagulation), congestive heart failure 
(CHF), coronary artery disease, obesity, chronic respiratory disease, functionally-
dependent status, diabetes mellitus, type of fracture (femoral neck or intertrochanteric), 
type of surgery (CRIF, ORIF, hemiarthroplasty, total arthroplasty), and type of hospital 
(academic or non-academic). Age, gender, comorbidities, and hospital type are reported 
in NTDB as chart-abstracted data elements. Fracture classification and type of surgery 
are reported as ICD-9 codes.  
 After review of initial results from the national cohort, more focused risk factors 
were identified for analysis in the institutional cohort. Gender was analyzed while age 
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was not, as this was not significant even in the large national cohort. As coagulopathy 
was a significant risk factor in the national cohort, in the institutional cohort preoperative 
anemia (hematocrit < 30%), chronic warfarin anticoagulation therapy, other chronic 
anticoagulation therapy, and regular aspirin use were studied as risk factors. As CHF was 
a significant risk factor in the national cohort, recent exacerbation of CHF symptoms and 
inpatient furosemide therapy were studied as risk factors. Coronary artery disease, 
obesity, and transfer from an outside hospital (OSH) were studied as risk factors. In 
addition, type of hip fracture and type of surgery were studied as in the national cohort. 
All patient level data was determined based on chart-review or ICD-9 coding (for fracture 
type and surgery type). 
The primary outcome measure in this study is surgical timing. Time from initial 
hospital admission to start of surgical intervention was calculated for each patient. 
Surgical start time was defined as time of initial incision.  
  
Statistical analysis, study size 
 The mean (and standard deviation) time to surgery was computed in each cohort. 
In addition, the mean (and standard deviation) time to surgery was determined for 
patients with each risk factor studied. Multivariate regression analysis was used to 
determine the independent effect of each risk factor on surgical timing (in hours) in both 
cohorts. In the national cohort, 44,900 patients were analyzed. In the institutional cohort, 
1,196 patients were analyzed.  
All statistical analyses were performed using Stata® version 13.0 (StataCorp, LP, 
College Station, Texas, USA). All statistical tests were two-tailed and the level of 
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statistical significance was set at α = 0.05. In order to reduce risk of a type 1 error, a 
Bonferroni correction was used to determine the threshold for statistical significance. 
Based on the 18 different hypotheses tested, the level of statistical significance was 
reduced to α = 0.003. 
 
Demographic, description of study population 
 Of the 44,900 patients in the national cohort, 32,337 (72%) were female and 
12,563 (28%) were male. The median age was 81 years (interquartile range [IQR]: 74 – 
85; note that NTDB limits maximum age to 89 years). A total of 18,983 patients had 
intertrochanteric fracture (42%), while 7,390 had femoral neck fractures (16%), and 
18,527 had unspecified hip fractures (41%). A total of 11,069 patients underwent CRIF 
surgery (25%), 19,030 underwent ORIF surgery (42%), 12,904 underwent 
hemiarthroplasty surgery (29%), and 1,897 underwent total arthroplasty surgery (4%). 
Of the 1,196 patients in the institutional cohort, 866 (72%) were female and 330 
(28%) were male. The median age was 85 years (interquartile range [IQR]: 78 – 90). A 
total of 626 patients had intertrochanteric fracture (52%), while 450 had femoral neck 
fractures (38%), and 120 had unspecified hip fractures (10%). A total of 115 patients 
underwent CRIF surgery (10%), while 699 underwent ORIF surgery (58%), 160 
underwent hemiarthroplasty surgery (13%), 35 underwent total arthroplasty surgery 





 The median time to surgery in the national cohort was 24 hours (IQR: 17 – 39 
hours). The distribution of time to surgery can be seen in Figure 1, with the number of 
patients who would have been considered as having had appropriate early surgery as 
indicated by the 2014 AAOS Guideline (86%), the 2010 UK NHS Best Practice Tariffs 
(74%), and the 2015 Danish Hip Fracture Registry Study (11%).  
 
 
Figure 1: Distribution of surgical timing in the national elderly hip fracture cohort  
(2011 – 2012 NTDB, n = 44,900) 
 
 Patient / surgical variables for this cohort are presented in Table 1, with the 
number of patients and median time to surgery indicated in the first two data columns. Of 
all the risk factors for delay surgery that were studied, the highest median time to surgery 
was for patients with coagulopathies at 30 hours (IQR: 20 – 48 hours), congestive heart 
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failure at 28 hours (IQR: 19 – 48 hours), coronary artery disease at 28 hours (IQR: 19 – 
47 hours), and total arthroplasty at 27 hours (IQR: 19 – 45).  
 Multivariate analysis for factors significantly associated with time to surgery was 
then performed (Table 1, last two data columns).  All risk factors had a statistically 
significant association with time to surgery except for age. The greatest independent 
effect sizes were for total arthroplasty at 7.7 additional hours (95% C.I.: 6.1 – 9.3 hours), 
coagulopathy at 7.1 additional hours (95% C.I.: 6.1 – 8.0 hours), and congestive heart 
failure at 6.9 additional hours (95% C.I.: 6.0 – 7.9 hours). 
 
Institutional cohort 
 The median time to surgery in the institutional cohort was 25 hours (IQR: 18 – 39 
hours). The distribution of time to surgery can be seen in Figure 2, with the number of 
patients who would have been considered as having had appropriate early surgery as 
indicated by the 2014 AAOS Guideline (85%), the 2010 UK NHS Best Practice Tariffs 
(73%), and the 2015 Danish Hip Fracture Registry Study (11%).  
 Patient / surgical variable for this cohort are presented in Table 2., with the 
number of patients and median time to surgery indicated in the first two columns.  Of all 
the risk factors for delay surgery that were studied, the highest median time to surgery 
was for patients with total arthroplasty at 42 hours (IQR: 24 – 68 hours), inpatient 
furosemide therapy for CHF exacerbation at 41 hours (IQR: 30 – 53 hours), warfarin  
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Table 1: Multivariate of risk factors for surgical delay in the 
national cohort 
  
Risk factor  














     Gender 
    Female 32,337 (72%) 23 (17 - 38) Reference - 
Male 12,563 (28%) 24 (17 - 41) 2.1 (1.4 - 2.7) < 0.001 
     Age 
    65- 69 5,211 (12%) 23 (16 - 38) Reference - 
70 - 74 6,161 (14%) 23 (16 - 38) -0.7 (-1.8 - 0.5) 0.245 
75 - 79 8,364 (19%) 24 (17 - 39) 0.3 (-0.7 - 1.4) 0.583 
80 - 84 12,131 (27%) 24 (17 - 39) 0.3 (-0.8 - 1.3) 0.622 
85+ 13,033 (29%) 24 (17 - 39) -0.3 (-1.3 - 0.7) 0.556 
     Comorbidities 
    Coagulopathy 4,848 (11%) 30 (20 - 48) 7.1 (6.1 - 8.0) < 0.001 
Congestive heart failure 4,824 (11%) 28 (19 - 48) 6.9 (6.0 - 7.9) < 0.001 
Coronary artery disease 1,605 (4%) 28 (19 - 47) 3.8 (2.2 - 5.4) < 0.001 
Obesity 1,730 (4%) 26 (18 - 45) 3.7 (2.2 - 5.2) < 0.001 
Chronic respiratory disease 6,732 (15%) 25 (18 - 42) 2.9 (2.0 - 3.7) < 0.001 
Functionally dependent 2,386 (5%) 25 (18 - 41) 2.2 (0.9 - 3.5) 0.001 
Diabetes mellitus  9,787 (22%) 25 (17 - 42) 2.0 (1.2 - 2.7) < 0.001 
     Fracture type (*) 
    Femoral neck 7,290 (16%) 25 (18 - 41) 2.3 (1.3 - 3.3) < 0.001 
Pertrochanteric 18,983 (42%) 23 (16 - 36) Reference - 
     Procedure type (*) 
    CRIF 11,069 (25%) 22 (15 - 33) Reference - 
ORIF 19,030 (42%) 24 (17 - 40) 3.3 (2.6 - 4.1) < 0.001 
Hemi arthroplasty 12,904 (29%) 24 (17 - 40) 2.9 (2.0 - 3.8) < 0.001 
Total arthroplasty 1,897 (4%) 27 (19 - 45) 7.7 (6.1 - 9.3) < 0.001 
     Non-academic hospital 31,688 (71%) 23 (16 - 37) Reference - 
Academic hospital 13,212 (29%) 24 (17 - 42) 4.1 (3.4 - 4.7) < 0.001 
          
ORIF = open reduction and internal fixation, CRIF = closed reduction and internal fixation 
Asterisks (*) indicate data elements with incomplete classification to due nonspecific coding of 
fracture types or procedure types. 
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anticoagulation at 40 hours (IQR: 27 – 60 hours), and other chronic anticoagulation at 36 
hours (IQR: 24 – 61).  
 
Figure 2: Distribution of surgical timing in the single-institution elderly hip fracture cohort (n = 1,196) 
 
Multivariate analysis for factors significantly associated with time to surgery was 
again performed (Table 2, last two columns).  Only 5 risk factors had a statistically 
significant association with time to surgery: total arthroplasty at 24.0 additional hours 
(95% C.I.: 13.2 – 34.8 hours), transfer from outside hospital at 22.0 additional hours 
(95% C.I.: 15.0 – 29.0 hours), warfarin anticoagulation at 13.4 additional hours (95% 
C.I.: 8.2 – 18.5 hours), other anticoagulation therapy at 10.0 additional hours (95% C.I.: 
1.9 – 18.0 hours), and recent CHF exacerbation at 7.7 additional hours (95% C.I.: 1.8 – 
13.6 hours). 
Table 2: Multivariate of risk factors for surgical delay in the institutional cohort 
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Risk factor  














     Gender 
    Female 866 (72%) 25 (18 - 37) Reference - 
Male 330 (28%) 26 (18 - 42) 0.9 (-2.8 - 4.5) 0.640 
     Medical risk factors 
    Transfer from OSH 66 (6%) 32 (17 - 60) 22.0 (15.0 - 29.0) < 0.001 
Warfarin anticoagulation 131 (11%) 40 (27 - 60) 13.4 (8.2 - 18.5) < 0.001 
Other anticoagulation 50 (4%) 36 (24 - 61) 10.0 (1.9 - 18.0) 0.015 
Recent CHF exacerbation 99 (8%) 29 (23 - 43) 7.7 (1.8 - 13.6) 0.011 
Inpatient furosemide 16 (1%) 41 (30 - 53) 5.7 (-8.2 - 19.6) 0.421 
Coronary artery disease 234 (20%) 28 (21 - 42) 3.0 (-1.2 - 7.2) 0.157 
Hematocrit < 30 86 (7%) 28 (20 - 43) 2.3 (-3.9 - 8.5) 0.460 
Obesity 25 (2%) 27 (21 - 41) 0.9 (-10.2 - 12.0) 0.879 
Aspirin therapy 261 (22%) 26 (20 - 39) 0.7 (-3.2 - 4.6) 0.721 
     Fracture type (*) 
    Femoral neck 450 (38%) 27 (20 - 42) 1.4 (-3.0 - 5.9) 0.529 
Pertrochanteric 626 (52%) 24 (17 - 37) Reference - 
     Procedure type (*) 
    CRIF 115 (10%) 24 (15 - 31) Reference - 
ORIF 699 (58%) 24 (17 - 37) 4.6 (-1.0 - 10.2) 0.104 
Hemi arthroplasty 160 (13%) 27 (20 - 39) 6.1 (-1.0 - 13.1) 0.095 
Total arthroplasty 35 (3%) 42 (24 - 68) 24.0 (13.2 - 34.8) < 0.001 
          
OSH = outside hospital 
    CHF = congestive heart failure 
   CRIF = closed reduction and internal fixation 
  ORIF = open reduction and internal fixation 
Asterisks (*) indicate data elements with incomplete classification to due nonspecific 




Substantial existing evidence supports earlier surgery after elderly hip fractures 38-
48, 52. Current national guidelines in the United States and United Kingdom recommend 
surgery within 48 hours and 36 hours of admission, respectively 49-51. In addition, a recent 
study using the Danish Hip Fracture Registry has shown surgery delayed later than 12 
hours after admission was associated with increased 30-day mortality 52. With more 
ongoing research evaluating potential benefits with even earlier surgery after hip fracture, 
we may very soon see recommendations for surgery within even shorter time intervals. 
These recommendations for early surgery after elderly hip fracture may even become tied 
to hospital or physician reimbursement as in the U.K. In order to eventually reduce the 
overall time to surgery, changes in staffing of orthopaedic surgeons will be a necessary 
step.  
The current study aims to identify potentially modifiable factors that may allow us 
provide earlier surgery for hip fracture patients. First, patient factors were analyzed in a 
national cohort of patients to identify broad factors associated with surgical delays. 
Second, the findings from the national-level analysis were used to identify modifiable 
factors associated with delays in an institutional cohort. While a number of factors had 
significant associations with later surgery in the national cohort, focused analysis in the 
institutional cohort demonstrated that management of chronic anticoagulation, recent 
CHF exacerbations, patient’s requiring arthroplasty surgery, and patients transferred from 
an OSH are all factors to be addressed in order to reduce overall time to surgery. 
Limitations 
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The current study has a number of limitations. First, as with any study using a 
large clinical database, the quality of results is dependent on the quality of data contained 
in the database. Fortunately, NTDB does include specific data elements for various 
comorbidity diagnoses that have been shown to be more accurate than the ICD-9 billing 
codes utilized in other databases 55. Nevertheless, the accuracy of data entry in NTDB is 
institution-dependent and there may be inconsistencies and systematic biases. For this 
reason, the current study takes the further step of verifying the results of the national 
cohort analysis using an institutional cohort and conducting a more focused analysis.  
A second limitation of the current study is the inability to characterize all factors 
that may be related to delays in surgery. Individual cases of logistical, staffing, or clinical 
delays likely occur with most patients, and cannot be well delineated even with chart-
review. As a result, this study attempts to take a bird’s eye view and identify potentially 
modifiable factors that may have the biggest impact on overall surgical timing. Any 
large-scale attempt to reduce the overall time to surgery after trauma would likely benefit 
from standardized protocols that eliminate systemic logistical and staffing delays.  
National Cohort 
Based on the results of our national cohort analysis, gender, all medical 
comorbidities, type of fracture, type of surgery, and hospital type had statistically 
significant associations with surgical timing. The largest effect sizes were for total 
arthroplasty (7.7 hours), coagulopathy (7.1 hours) and congestive heart failure (6.9 
hours), all of which we chose to analyze in greater detail in our institutional cohort 




Figure 3: Diagram of step-wise selection of focused, modifiable risk factors for analysis between the 
national cohort and the institutional cohort. Circles indicate risk factors that were statistically significant 
(light green in the national cohort represents regression coefficient s< 3.0). X’s indicate risk factors that 
were not statistically significant or did not have associations with an effect size that met a predetermined 
threshold. Note: CHF = congestive heart failure, Hct = hematocrit. 
 
Coronary artery disease and obesity were two factors found to be associated with 
independent delays of over 3 hours in the national cohort. One previous analysis of over 
600 patients at one level 1 trauma center found that patient requiring preoperative cardiac 
testing were delayed 1.5 more days prior to surgery, compared to those who are not 56, 
while longer time to surgery associated with obesity has not previously been shown. Both 
obesity and coronary disease are known to predispose patients to a number of 
preoperative risk factors for postoperative complications, risk factors that may necessitate 
preoperative cardiac, respiratory, endocrine, and volume status screening 57, 58. While this 
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screening is no doubt necessary, in order to reduce surgical timing after hip fractures in 
the future this screening also must be expedited for patients with body mass indices 
greater than determined thresholds.  
Institutional Cohort 
In the institutional cohort, total arthroplasty surgery was associated with the 
greatest delay (24.0 additional hours) and presumably was largely due to the lack of 
availability of specialized arthroplasty surgeons who may not be available for urgent 
surgery at time of patient admission. Additional risk factors that were identified were 
transfers from outside hospitals, warfarin anticoagulation, other chronic anticoagulation, 
and recent CHF exacerbation.  
Based on these findings two modifiable aspects of hip fracture management may 
be appropriate aims for future investigation. First, timely availability of the correct 
surgeon and surgical staff is essential for early operative management, especially if hip 
fracture guidelines are revised with earlier goals. Longer time to hip fracture surgery for 
patients requiring total hip arthroplasty suggests that staffing of arthroplasty surgeons 
may be lacking compared to surgeons able to perform an ORIF of a hip fracture. Urgent 
total hip arthroplasty has previously been shown to be associated with higher total 
hospital costs and perioperative complications compared to elective arthroplasty 59. 
Nevertheless, long-term outcomes after total hip arthroplasty for elderly hip fractures are 
good 60. The ongoing Hip fracture Evaluation with ALternatives of THA versus 
Hemiarthroplasty (HEALTH) trial is investigating the superiority of hemi- versus total- 
arthroplasty after elderly hip fractures 61. If the HEALTH trial does demonstrate better 
long-term outcomes with THA, then THA may become the new standard of care for 
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elderly femoral neck fractures, further necessitating increased staffing of arthroplasty 
surgeons. However, if the benefits of THA over hemiarthroplasty are negligible then the 
large delays associated with THA may outweigh these benefits. This would then suggest 
that hemiarthroplasty, performed in a timely manner, be the treatment of choice. The 
growing concept of specialized hip fracture services, with expedited pathways to 
appropriate surgical treatment may be a suitable solution 62-64.  
A second aspect of care that may be modified is medical co-managemnt of hip 
fracture patients. Both warfarin and alternative therapies for chronic anticoagulation were 
associated with large delays to surgery (13.4 and 10.0 additional hours, respectively). 
This accounted for 15% of our institutional cohort (177 patients). Reversal of chronic 
anticoagulation prior to surgery is clearly necessary to avoid excessive bleeding. 
However, with more pressure to operate on hip fracture earlier, more rapid medical 
strategies for reversal may be warranted. This may be optimally managed by an inpatient 
medical service that is co-managing hip fracture patients in concert with the surgical 
team. Previous studies of prothrombin complex concentrate (PCC) for reversal of vitamin 
K antagonist anticoagulation, have shown good safety and effectiveness when used prior 
to acute surgery 65, even when compared to fresh frozen plasma 66. While this relatively 
new treatment is expensive, several analyses have demonstrated that use of PCC for rapid 
warfarin reversal after hip fractures is actually cost effective, due to reduce preoperative 
hospital time and shorter postoperative length of stay 67-69. Adoption of rapid warfarin 
reversal protocols by medical teams may be a very effective method to reduce time to 
surgery for a large subset of hip fracture patients. For patients taking new oral 
anticoagulants (NOACs), PCC has also been shown to effectively reverse both the factor 
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Xa inhibitor rivaroxaban and the thrombin inhibitor dabigatran in one prospective 
randomized controlled trial 70. Recent CHF exacerbations were also associated with a 
delay to surgery of 7.7 hours in the institutional cohort. This was largely due to need for 
preoperative medical screening and the rare circumstance of a patient presenting acute 
with decompensated CHF. Co-management by a medical team with standardized 
preoperative screening algorithms for patients with preexisting CHF may help to more 
rapidly identify patients who are too high-risk for surgical intervention. 
Conclusion 
In conclusion, the current study utilizes a large national cohort and an institutional 
cohort to identify modifiable risk factors for delayed hip fracture surgery. Based on the 
current findings, more aggressive reversal of chronic anticoagulation would be an 
effective mean to reduce delays in a large subset of the population. Standardized 
preoperative screening algorithms, which focus on identifying patients who are poor 
surgical candidates, would also help reduce preoperative delays. Additionally, if use of 
total hip arthroplasty to manage hip fractures increases, bases on current ongoing clinical 
trials, improved staffing of arthroplasty surgeons may also be warranted. Ultimately, with 
the growing body of research showing benefits with hip fracture fixation within 24 hours 
or even earlier, strategies for reducing our current preoperative interval are necessary. 
While standardized admission protocols and order sets will be necessary to reduce 
logistical and administrative delays, the current study identifies certain patient factors that 
providers should also be prepared to manage aggressively in order to achieve optimal 
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The current Medicare Acute Inpatient Prospective Payment System determines 
hospital reimbursement for inpatient admissions by categorizing patients into Diagnosis-
related Groups (DRGs), originally meant to create patient classes that are “clinically 
consistent and that have similar patterns of output utilization” 71.  When first 
implemented in 1983, the DRG model represented a substantial shift away from 
traditional cost-based billing, transferring both risk and potential cost-savings to hospitals 
72. Regardless of true hospital costs, all inpatient admissions under the same DRG are 
reimbursed using the same “bundled” payment, the only exception being a 
reimbursement modifier for either major or minor patient complications and/or 
comorbidities.  
Although the DRG system has no doubt resulted in Medicare cost savings, proper 
division of patients into DRGs is critical to prevent under-reimbursement to hospitals or 
wasted Medicare payments. Under the current Medicare Severity (MS)-DRG system, 
MS-DRG 536 (fractures of the hip and pelvis) encompasses a large number of elderly 
orthopaedic trauma patients. While the age-adjusted incidence of elderly fractures has 
declined since 2005, the absolute incidence has increased dramatically due to the growing 
elderly population and is expected to continue to grow 73, 74. The U.S. population older 
than age 85 is expected to increase 3-fold between 2010 and 2050 73. In addition, elderly 
fractures can be costly to manage, as they often require surgical intervention. However, 
the average low-energy hip fracture and high-energy pelvic fracture, both included in 
DRG 536, are considerably different injuries with differing management courses and, 
likely, differing associated inpatient costs 75. Due to the common nature of these injuries, 
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these differences in costs may account for substantial sums. Classification of other 
Medicare DRGs for procedures such as total joint arthroplasty, spinal fusion, and 
coronary artery bypass grafting has been modified to take into account cost variations 76, 
77. For example due to higher hospital costs associated with revision arthroplasty, versus 
primary arthroplasty, these procedures were separated into a separate DRG with greater 
reimbursement rates 76-78. As the complexities of our current US healthcare environment 
make estimation of true healthcare costs difficult, several measures of hospital resource 
utilization were used as proxies for inpatient costs. In this way, differences in utilization 
can also be translated across health systems, regardless how cost accounting practices 
differ between individual institutions.  
The purpose of this study was to determine whether (1) inpatient length of stay; 
(2) intensive care unit (ICU) stay; and (3) ventilator time differ between subpopulations 
of Medicare DRG 536, even after controlling for hospital factors. 
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Patients and Methods 
A retrospective study was performed using the 2011 and 2012 American College 
of Surgeons National Trauma Data Bank Research Data Set. The National Trauma Data 
Bank is the largest national database of trauma cases including patients from over 900 
trauma centers annually. While other commonly studied national databases, such as the 
National Surgical Quality Improvement Program database, do not include non-operative 
patients or high-energy trauma patients, the National Trauma Data Bank allows analysis 
of both operative and non-operative patients sustaining both high-energy and low-energy 
injuries in centers across the U.S, or the full spectrum of patients in DRG 536. In 
addition, there are currently a number of methodologies used by healthcare economists 
and hospital administrators to calculate costs, with no consensus between institutions or 
researchers. The National Trauma Data Bank offers data on various measure of 
healthcare resource utilization, namely inpatient length of stay, ICU stay, and mechanical 
ventilation time, which may be used as proxies for inpatient costs. In this way, 
differences in utilization can also be translated across health systems, regardless of the 
differing cost accounting practices of individual institutions Human investigations 
committee approval was acquired before initiating the study.  
International Classification of Diseases, 9th Revision (ICD-9) diagnosis codes 
were used to identify patients in MS-DRG 536 based on diagnoses of acetabulum 
fractures, including both operative and non-operative, (ICD-9 808.0–808.1), other pelvic 
fractures (ICD-9 808.2–808.59), and hip fractures (ICD-9 820.20–820.32). Patients with 
other pelvic fractures were further subdivided into operative and non-operative pelvic 
fracture-based ICD-9 procedure codes (ICD-9 79.19, 79.29, 79.39, or 79.49). Note that 
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patients managed operatively versus non-operatively, or with internal fixation versus 
arthroplasty, would similarly be grouped into MS-DRG 536, regardless of ultimate 
treatment modality. Only patients within the Medicare age group (65 years or older) were 
included. 
A retrospective study was performed comparing inpatient length of stay, intensive 
care unit stay, and ventilator time among the four subpopulations of Medicare DRG 536. 
The three resource utilization measures of interest were reported as continuous variable in 
the National Trauma Data Bank. Multivariate analysis controlled for possible 
confounding patient and hospital factors including Charlson Comorbidity Index, hospital 
teaching status (university, community, or nonteaching), hospital size (≤ 200 beds, 201–
400 beds, 401–600 beds, or > 600 beds), and geographic region (by US Census regions: 
Northeast, Midwest, South, and West). The modified Charlson Comorbidity Index has 
been shown to have comparable predictive value to the original Charlson Comorbidity 
Index and have been used previously in studies of national databases with national 
databases studies 7, 8, 32. Computation of the modified Charlson Comorbidity Index was 
based on National Trauma Data Bank comorbidity and age data (Appendix 1; 
Supplemental materials are available with the online version of CORR®.). The hospital 
factors are reported in National Trauma Data Bank by participating institutions. Two 
additional possible confounding variables are month of admission and American College 
of Surgeons trauma center level. Previous studies have demonstrated that length of stay 
may vary according to a seasonal or “July” effect and by American College of Surgeons 
level. Unfortunately data on date or month of admission in unavailable in the database 
and data on American College of Surgeons level contains a large amount of missing data 
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(36%). However, as contributing trauma centers submit a full year of patient data to the 
National Trauma Data Bank, most seasonal variations can be expected to wash out. In 
addition, controlling for teaching status (non-teaching, community, or university) and 
hospital size should address much of the bias between American College of Surgeons 
levels. 
Statistical Analysis  
Multivariate linear regression was used to test the differences in outcome 
measures between subgroups after controlling for hospital factors. This was followed by 
Tukey’s post hoc pairwise comparisons to test the significance of individual comparisons 
between the four subpopulations. 
All statistical analyses were performed using Stata® Version 13.0 (StataCorp, LP, 
College Station, TX, USA). All statistical tests were two-tailed, and the level of 




Demographics, Description of Study Population 
A total of 58,977 patients met inclusion criteria. Of those, 35,119 patients had hip 
fractures, 15,506 had nonoperative pelvic fractures, 7670 had acetabulum fractures, and 
682 had operative pelvic fractures. Gender, age, Charlson Comorbidity Index, and Injury 
Severity Score varied predictably between groups (Table 1). Of note, 6,180 hip fracture 
patients (17.6% of all hip fractures) and 307 acetabular fracture patients (4.0% of all 
acetabular fractures) were treated with arthroplasty surgery (total hip arthroplasty or 
hemiarthroplasty).  
Inpatient length of stay 
Patients with operative pelvic fractures had the longest mean length of stay at 15.2 
days (SD: 13.6 days; Figure 1). Mean length of stay for hip fracture patients was 6.6 days 
(SD: 5.1 days), and this difference from operative pelvic fracture patients was statistically 
significant after controlling for patient and hospital factors (difference: 7.7 days [95% 
confidence interval: 7.0 to 8.4]; P < 0.001; Table 2). Non-operative pelvic fracture 
patients had a mean length of stay of 6.5 days (SD: 8.2 days), and this difference from 
operative pelvic fracture patients was statistically significant after controlling for patient 
and hospital factors (difference: 8.0 days [95% confidence interval: 7.3 to 8.6]; P < 
0.001). Acetabulum fracture patients had a mean length of stay of 8.7 days (SD: 9.5 
days), and this difference from operative pelvic fracture patients was statistically 
significant after controlling for patient and hospital factors (difference: 6.0 days [95% 
confidence interval: 5.4 to 6.8]; P < 0.001).   
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Table 1. Patient summary statistics 
Patient factors Hip fracture (n = 35,119) 
Nonoperative 
pelvic fracture (n = 
15,506) 
Acetabulum 
fracture (n = 7670) 
Operative pelvic 
fracture (n = 682) 
         Gender 
        Female 24,046 68% 11,685 75% 3377 44% 252 37% 
Male 11,073 32% 3821 25% 4293 56% 430 63% 
         Age (years) (mean = 80) (mean = 79) (mean = 77) (mean = 73) 
65-69 3702 10% 2002 13% 1804 24% 272 40% 
70-74 4573 13% 2105 14% 1437 19% 150 22% 
75-79 6472 18% 2773 18% 1352 18% 124 18% 
80-84 9670 28% 4172 27% 1626 21% 84 12% 
85+ 10,702 30% 4454 29% 1451 19% 52 8% 
         Charlson 
Comorbidity Index (mean = 5) (mean = 5) (mean = 4) (mean = 4) 
3 2219 6% 1553 10% 1304 17% 223 33% 
4 16,579 47% 8155 53% 3498 46% 303 44% 
5 9265 26% 3524 23% 1739 23% 101 15% 
6+ 7056 20% 2274 15% 1129 15% 55 8% 
         Injury Severity 
Score (mean = 10) (mean = 11) (mean = 12) (mean = 20) 
0-9 29,769 85% 10,052 65% 4445 58% 133 20% 
10-14 3778 11% 1996 13% 1099 14% 125 18% 
15-19 637 2% 952 6% 636 8% 117 17% 
20+ 935 3% 2506 16% 1490 19% 307 45% 
                  





Figure 1: Mean length of stay, inpatient care unit (ICU) stay, and mechanical ventilation time vary 
between patients in each subgroup of DRG 536. Error bars represent standard error of the mean. 
 
ICU stay 
Patients with operative pelvic fractures had the longest mean ICU stay at 7.4 days 
(SD: 10.5 days; Figure 1). Mean ICU stay for hip fracture patients was 0.7 days (SD: 2.7 
days), and this difference from operative pelvic fracture patients was statistically 
significant after controlling for patient and hospital factors (difference: 6.3 days [95% 
confidence interval: 5.9 to 6.7]; P < 0.001; Table 3). Non-operative pelvic fracture 
patients had a mean ICU stay of 1.6 days (SD: 4.7 days), and this difference from 
operative pelvic fracture patients was statistically significant after controlling for patient 
and hospital factors (difference: 5.4 days [95% confidence interval: 5.0 to 5.8]; P < 
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0.001). Acetabulum fracture patients had a mean ICU stay of 2.8 days (SD: 6.4 days), and 
this difference from operative pelvic fracture patients was statistically significant after 
controlling for patient and hospital factors (difference: 4.3 days [95% confidence interval: 
3.9 to 4.8]; P < 0.001).  
Ventilator Time  
Patients with operative pelvic fractures had the longest mean ventilator time at 4.5 
days (SD: 9.7 days; Figure 1). Mean ventilator time for hip fracture patients was 0.2 days 
(SD: 1.9 days), and this difference from operative pelvic fracture patients was statistically 
significant after controlling for patient and hospital factors (difference: 3.9 days [95% 
confidence interval: 3.6 to 4.2]; P < 0.001; Table 4). Non-operative pelvic fracture 
patients had a mean ventilator time of 0.8 days (SD: 3.9 days), and this difference from 
operative pelvic fracture patients was statistically significant after controlling for patient 
and hospital factors (difference: 3.4 days [95% confidence interval: 3.1 to 3.7]; P < 
0.001). Acetabulum fracture patients had a mean ventilator time of 1.5 days (SD: 5.1 
days), and this difference from operative pelvic fracture patients was statistically 
significant after controlling for patient and hospital factors (difference: 2.8 days [95% 
confidence interval: 2.5 to 3.2]; P < 0.001).  
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Table 2. Multivariate analysis of length of stay 
Outcome: inpatient length of 
stay 
     
Subpopulations of DRG 536 
Mean length of 










    
Hip fracture 6.6 (5.1) 7.7 (7.0-8.4) < 0.001 
Non-operative pelvic fracture 6.5 (8.2) 8.0 (7.3-8.6) < 0.001 
Acetabulum fracture 8.7 (9.5) 6.0 (5.4-6.8) < 0.001 
Operative pelvic fracture 15.2 (13.6) Reference - 
       
Patient and hospital factors 
(controlled for in multivariate 
analysis) 
 Regression 





Charlson Comorbidity Index  
  3  Reference 
 4  -0.5 (-0.7 to -0.3) < 0.001 
5  -0.1 (-0.4 to 0.1) 0.190 
6+  0.4 (0.2-0.6) 0.001 
 
 
  Hospital teaching status  
  Nonteaching  Reference 
 University  1.4 (1.3-1.6) < 0.001 
Community  0.4 (0.2-0.5) < 0.001 
 
 
  Hospital size (beds)  
  ≤ 200  Reference 
 201-400  0.5 (0.3-0.7) < 0.001 
401-600  1.0 (0.8-1.2) < 0.001 
> 600  1.4 (1.2-1.7) < 0.001 
 
 
  Geographic region  
  Northeast  Reference 
 Midwest  0.39 (0.2-0.6) < 0.001 
South  0.49 (0.4-0.6) < 0.001 
West  0.21 (0.0-0.4) 0.016 




Table 3. Multivariate analysis of ICU length of stay 
Outcome: intensive care unit 
days 
     
Subpopulations of DRG 536 
Mean intensive 










    
Hip fracture 0.7 (2.7) 6.3 (5.9-6.7) < 0.001 
Non-operative pelvic fracture 1.6 (4.7) 5.4 (5.0-5.8) < 0.001 
Acetabulum fracture 2.8 (6.4) 4.3 (3.9-4.8) < 0.001 
Operative pelvic fracture 7.4 (10.5) Reference - 
       
Patient and hospital factors 
(controlled for in multivariate 
analysis) 
 Regression 





Charlson Comorbidity Index  
  3  Reference 
 4  -0.4 (-0.6 to -0.3) < 0.001 
5  -0.4 (-0.5 to -0.2) < 0.001 
6+  -0.3 (-0.4 to -0.3) < 0.001 
 
 
  Hospital teaching status  
  Nonteaching  Reference 
 University  0.9 (0.8-1.0) < 0.001 
Community  0.1 (0.0-0.2) 0.012 
 
 
  Hospital size (beds)  
  ≤ 200  Reference 
 201-400  0.2 (0.0-0.3) 0.005 
401-600  0.4 (0.2-0.5) < 0.001 
> 600  0.7 (0.5-0.8) < 0.001 
 
 
  Geographic region  
  Northeast  Reference 
 Midwest  -0.3 (-0.4 to -0.2) < 0.001 
South  0.1 (0.02-0.2) 0.017 
West  0.3 (0.2-0.4) < 0.001 
       





Table 4. Multivariate analysis of ventilator days 
Outcome: mechanical 
ventilation days 
     
Subpopulations of DRG 536 
Mean mechanical 










    
Hip fracture 0.2 (1.9) 3.9 (3.6-4.2) < 0.001 
Non-operative pelvic fracture 0.8 (3.9) 3.4 (3.1-3.7) < 0.001 
Acetabulum fracture 1.5 (5.1) 2.8 (2.5-3.2) < 0.001 
Operative pelvic fracture 4.5 (9.7) Reference - 
       
Patient and hospital factors 
(controlled for in multivariate 
analysis) 
 Regression 





Charlson Comorbidity Index  
  3  Reference 
 4  -0.3 (-0.4 to -0.2) < 0.001 
5  -0.3 (-0.4 to -0.2) < 0.001 
6+  -0.3 (-0.4 to -0.2) < 0.001 
 
 
  Hospital teaching status  
  Nonteaching  Reference 
 University  0.6 (0.5-0.7) < 0.001 
Community  0.1 (0.1-0.2) < 0.001 
 
 
  Hospital size (beds)  
  ≤ 200  Reference 
 201-400  0.0 (0.0 to 0.1) 0.346 
401-600  0.2 (0.0-0.2) 0.004 
> 600  0.4 (0.2-0.5) < 0.001 
 
 
  Geographic region  
  Northeast  Reference 
 Midwest  -0.2 (-0.2 to -0.1) < 0.001 
South  0.1 (0.0-0.2) 0.002 
West  0.1 (0.1-0.2) 0.001 





The current Medicare Acute Inpatient Prospective Payment System determines 
reimbursement for inpatient admissions by categorizing patients into 746 MS-DRGs that 
are annually revised. Inpatient admissions under the same DRG are reimbursed with the 
same prospective, “bundled” payment, regardless of actual hospital costs. Currently, 
DRG 536 (fractures of the hip and pelvis) includes a broad spectrum of orthopaedic 
injuries, from low-energy fragility fractures of the hip to high-energy acetabulum and 
pelvic fractures. With the absolute incidence of elderly fractures expected to increase 
dramatically due to the growing elderly population 73, 74 and the high costs of managing 
these injuries,, any substantial variation in costs may result in over- or under-
reimbursement to certain hospitals, based on their percentage of high-energy versus low-
energy elderly fractures treated. Excess financial strain on these hospitals treating high-
energy trauma patients may even result trauma center closures or shifts away from 
managing high-energy trauma, resulting in reduced access for these patients. Similar 
discrepancies between hospital costs and Medicare reimbursements have also been seen 
within other Medicare DRGs in the past 76, 77.  The results of the current study 
demonstrate that, even after controlling for patient and hospital factors, there were 
important differences in various measures of resource utilization between the four 
subgroups of Medicare DRG 536. These differences indicate that hospitals are currently 
receiving under- or over-reimbursement for certain subgroups, depending on their 
baseline reimbursement for DRG 536. In particular, these increases in resource utilization 
were most striking for patients with the fractures more likely to be associated with higher 
energy mechanisms: operative pelvic fractures and acetabulum fractures.  
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The primary limitation of this study stems from this exclusion of true cost figures. 
Standard methods of healthcare cost estimation have important limitations. Cost 
measurement using charges or cost-to-charge ratios estimates only total costs, and not the 
marginal costs of services, and ignores cost shifting that occurs regularly in hospital 
accounting 79, 80. However, the current study uses various measures of resource utilization 
as a proxy for costs. With the estimated costs of an inpatient day at USD 1236, an ICU 
day at USD 2278 to USD 5973, and a day on mechanical ventilation at USD 10,299 81, 82, 
the results presented in the current study do represent significant differences between 
subpopulations of DRG 536. An additional limitation of this study is the inability to 
identify patients with major complications or comorbidities (MCCs), who might be 
classified into DRG 535 (fractures of the hip or pelvis with MCCs) based on the ICD-9 
diagnosis data given in the National Trauma Data Bank. The authors acknowledge that 
inability to identify patients with major complications or comorbidities may result in 
overestimation of resource utilization for the subgroups of DRG 536 that are associated 
with higher rates of major comorbidities and complications. Higher-energy fractures, 
associated with greater total burden of bodily injury, may very likely also be associated 
with greater inpatient complications due to more complex inpatient course and longer 
length of stay. In addition, lower energy fractures associated with osteoporosis may also 
be associated with higher rates of comorbidities and complications, due to poorer overall 
health status. However, by controlling for Charlson Comorbidity Index, the current study 
shows differences in resource utilization that are independent of age and comorbidities. 
These differences likely indicate disparities in resource utilization for patients in both 
DRG 535 and DRG 536. Nevertheless, further study using true cost figures and DGR 
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classifications at a single-institution is warranted to estimate the actual financial burden 
caused by the large spectrum of patients included in DRG 536. 
Another limitation of the current study results from the inherent biases associated 
with using a national dataset such as the National Trauma Data Bank. While the NTDB 
includes data from over 900 trauma centers, this data is self-reported by hospitals and 
accuracy is dependent on the accuracy of data submitted from individual hospitals. 
Hospital may submit incomplete datasets resulting in over- or under representation of 
certain fracture types. Nevertheless, the large overall size of the dataset allowed 
statistically significant differences to be identified, despite large disparities in sample size 
between subpopulations (there were far more hip fractures than operative pelvic 
fractures). Selection bias is also possible as the dataset, while including data from over 
900 U.S. trauma centers, is not necessarily nationally representative. There may certainly 
be biases toward level I and II trauma centers which see greater numbers of high-energy 
trauma patients. Nevertheless, the aim of the current study was not to measure the relative 
incidences of the different subpopulations included in MS-DRG 536, but rather to 
compare how resource utilization varies between patients with these different 
subpopulations. By controlling for hospital factors, such as hospital size, teaching status, 
and geographic region, the current study attempts to control for local variations in 
resource utilization and isolate the differences in utilization attributable to the various 
injury types. Another type of bias that may be present is transfer bias, as a percentage of 
patients in the National Trauma Data Bank have incomplete data regarding inpatient 
length of stay, ICU stay, or ventilator time. These patients were excluded from the 
analysis. Of a total of 69,055 patients in MS-DRG 536 and aged 65 or older in the 
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National Trauma Data Bank, 10,078 patients were dropped due to incomplete data in 
regards to inpatient length of stay (n = 478), ICU stay (n = 7,484), or ventilator time (n = 
8,534) resulting in the 58,977 patients ultimately analyzed. It may be that patients with 
more severe acute injuries and complicated inpatient courses represent a higher 
percentage of these patients with incomplete data, biasing the current study results. 
However, in a post hoc analysis the mean Injury Severity Score for these dropped 
patients was 9.9, compared to 10.6 in the analyzed patients. This difference of 0.7 in 
Injury Severity Score, while statistically significant (P < 000.1) due to large sample size, 
was not clinically significant.  
Previous work in the field of orthopaedics showed similar differences in inpatient 
costs and resource utilization between primary and revision total joint arthroplasty 77, 78, 
at the time both grouped under Medicare DRG 209 (lower extremity arthroplasty). An 
initial multicenter cohort study demonstrated differences in operative time, use of 
allograft, length of stay, and costs, between almost 8,000 patients undergoing either 
primary or revision hip and knee arthroplasty 78. A subsequent study at a single institution 
demonstrated mean differences in hospital costs of over $7,000 per patient between 
revision and primary arthroplasty patients 77. This work ultimately supported efforts by 
the American Association of Orthopaedic Surgeons, the American Association of Hip 
and Knee Surgeons, and the Hip Society to propose modification of the DRG to the 
Centers for Medicare & Medicaid Services (CMS). This was ultimately accepted in 2005 
with creation of two new DRGs: DRG 544 (primary hip and knee replacement) and DRG 
545 (revision hip and knee replacement) 76. Similar efforts with DRG 536 should be 
pursued, next with analysis of true cost figures. This should be conducted within a single 
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institution because comparing hospital costs between multiple institutions becomes 
complicated due to varying cost accounting practices. In addition, further investigation of 
other MS-DRGs that include a broad spectrum of orthopaedic patients may be warranted. 
One such example is DRG 563, which includes all fractures, sprains, strains, and 
dislocations, excluding those of the femur, hip, and pelvis. 
A secondary finding of the current study was the associations of patient and 
hospital factors with resource utilization. As expected, increased Charleston Comorbidity 
Index is associated with increased costs, likely due to increased resources necessary to 
treat patients with worse overall health status.  In addition, it was found that larger 
hospitals and University hospitals were associated with increased utilization. This would 
be expected as more critically injured patients are often seen in larger, university-
associated trauma centers 83. Previous studies have demonstrated worse outcomes for hip 
fractures managed at teaching hospitals compared to non-teaching hospitals, suggesting 
more severely injured patients. In addition, a previous study specifically demonstrated 
increased resource utilization in university hospitals compared to community teaching 
hospitals for tPA treated stroke patients 84. The geographic differences observed have not 
been previously described but likely results from regional variations in hospital practices 
and physician customs for inpatient discharge and ICU transfer. 
Now may be an opportune time for CMS to reevaluate classification of DRG 536 
because the Medicare DRG system may soon see more-expanded use. As part of the 
Patient Protection and Affordable Care Act (PPACA), the CMS Bundled Payments for 
Care Improvement Initiative will test new bundled payment delivery models aimed at 
reducing costs and improving quality of care 85. Three of the four proposed models, all 
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currently being tested, expand bundling of payments to include services outside of 
inpatient hospital care including physician services and postacute care services. All four 
models use the current MS-DRG system to categorize patients. The American 
Association of Hip and Knee Surgeons has already created a Bundled Payment Task 
Force to identify issues in the system specific to hip and knee surgeons and to aid in the 
eventual transition 86, 87. In addition, many private health plans, which cover patients of 
all ages, use a MS-DRG based model for reimbursement. However, as low-energy 
fragility fractures are less common in younger patients we would expect less variation in 
resource utilization between patients with hip or pelvis fractures, which would all more 
likely result from higher energy mechanisms.  Similar measures should be taken 
throughout the field of orthopaedic surgery, including in the field of orthopaedic trauma, 
which sees over two million elderly patients with fragility fractures annually 88.  
In conclusion, the current study demonstrates considerable variation in resource 
utilization for hospital admissions due to hip or pelvis fractures, which are all reimbursed 
equally under DRG 536. With the current multitiered US trauma system, it is very likely 
that some trauma centers treat a higher proportion of the more the resource-intensive 
injuries, resulting in higher costs and lower financial margins. Appropriate 
reimbursement of hospital services is essential for maintaining patient access to inpatient 
care in the currently shifting US healthcare landscape. Therefore, creating a separate MS-
DRG for operative pelvic fractures and acetabulum fractures would likely help reduce 
this financial strain. Further comparison of true cost figures at a single institution may be 
a suitable next step to demonstrate clear financial benefits of regulatory changes. Indeed, 
just as new healthcare standards and quality benchmarks are currently being developed in 
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the field of orthopaedics to meet PPACA guidelines, the classification of Medicare DRGs 




Conclusion of Thesis 
 The preceding three studies illustrate the utility of “big data” for studying 
orthopaedic trauma patients, a unique patient population that may require special 
considerations when designing clinical analyses.  In Section I, we demonstrated that not 
all national databases capture the typical high-energy fracture populations well, including 
the commonly used NSQIP database that primarily includes elderly fragility type fracture 
patients. As a result, fully understanding the populations contained in various national 
databases is critical before designing or evaluating database research. Trauma specific 
databases such as NTDB are best suited to study high-energy trauma patients, however 
they are not as nationally representative of fracture patients as databases with systematic 
sampling techniques, such as NIS. 
 In Section II the NTDB was utilized to identify a number of risk factors 
associated with delayed hip fracture surgery, including coagulopathy, congestive heart 
failure, and arthroplasty surgery. These findings were then used to conduct a more in 
depth analysis using a local cohort of hip fracture patients. It was found that total hip 
arthroplasty was associated with the greatest delays of over 24 hours, while warfarin 
anticoagulation, other chronic anticoagulation, and recent CHF exacerbations were 
additional risk factors. The importance of appropriate surgeon staffing and medical co-
management of patients were highlighted as possible areas for improvement with 
increasing evidence and guidance for earlier surgical intervention after hip fractures. 
 Finally in Section III the NTDB was again used to demonstrate that management 
of both operative pelvic fractures and acetabulum fractures require substantially greater 
hospital resource utilization, compared to hip fractures or non-operative pelvic fractures. 
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This finding is interesting as hospitals are reimbursed equally for treatment of each of 
these types of fractures under Medicare DRG 536. For hospitals that manage a relatively 
greater number of higher energy injuries, such as acetabulum fractures or operative pelvic 
fractures, financial returns per patient would be lower relative to other hospitals. As a 
result, refinement of this Medicare DRG to separate these higher cost injuries was 
recommended, just as has been done for primary and revision arthroplasty patients, who 
were also previously grouped into the same Medicare DRG.  
 In conclusion, thoughtfully designed clinical studies using “big data” will 
continue to be used to study orthopaedic trauma populations, and these studies will be 
both hypothesis-finding and hypothesis-testing. While there remain limitations to national 
databases that are currently in use, many of these limitations can be addressed with 
thoughtful design of orthopaedic trauma-focused databases in the future. A hip fracture-
specific NSQIP dataset, currently in data collection phase, is a first step, while 
development of robust institutional orthopaedic trauma registries at busy trauma centers, 
which may even leverage electronic health records for automated data collection, may 
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Appendix 1: Data elements used to identify comorbidities in NIS, NSQIP, and NTDB 
 
Comorbidity NIS data element NSQIP data element NTDB data element 
Alcoholism   “cm_alcohol” 
(Alcohol abuse) 
  “etoh” (EtOH > 
drinks/day in 2 wks 
before admission) 






  “bleeddis” (Bleeding 
disorders) 











  “diabetes" (Diabetes 
mellitus with oral 
agents or insulin) 








“  comorkey” = 12 
(Disseminated cancer) 







  “comorkey” = 19 
(Hypertension 
requiring medication) 
Obesity   “cm_obese” 
(Obesity) 
  “height” (Height) 
  “weight” (Weight)† 
  “comorkey” = 22 
(Obesity) 
Current smoker  ICD-9 diagnosis 
305.1 (Tobacco Use 
Disorder) 
  “smoke” (Current 
smoker within one 
year) 
  “comorkey" = 8 
(Current smoker) 






Appendix 2: Data elements used to identify inpatient adverse events in NIS, NSQIP, and 
NTDB 
 
Adverse event NIS data element or ICD-
9 diagnosis code 
NSQIP data element NTDB data element 
Acute kidney 
injury 
• 584.X (Acute kidney 
injury) 
• “noprenafl” (Acute renal 
failure, postoperative) 
• “nreninsf” (Progressive renal 
insufficiency, postoperative) 
• “complkey” = 4 (Acute 
kidney injury) 
Cardiac arrest • 427.41 (Ventricular 
fibrillation) 
• 427.5 (Cardiac arrest) 
• “ncdarrest” (Cardiac arrest 
requiring cardiopulmonary 
resuscitation, postoperative) 
• “complkey” = 8 




• 430 (Subarachnoid 
hemorrhage) 
• 431 (Intracerebral 
hemorrhage) 
• 433.X1 (Precerebral 
artery occlusion and 
stenosis with cerebral 
infarction)   
• 434.X1 (Cerebral artery 
occlusion with cerebral 
infarction)   
• 997.02 (Iatrogenic 
cerebrovascular infarction 
or hemorrhage)   
• “ncnscva” (Stroke/CVA, 
postoperative) 
• “complkey” = 22 
(Stroke / CVA) 
Death • “died” (Death) • “dopertod” ≤ “doptodis” 
(Date of death ≤ Date of 
discharge) 
• “hospdisp” = “Expired” 
(Death) 







• 415.1 (Pulmonary 
embolism) 
• 452.X-454.X, 453.82, 
453.84, 453.85, 453.86 
(Acute embolism and 
thrombosis of deep vein) 
• “nothdvt” (DVT, with or 
without inflammation, 
postoperative) 
• “npulembol” (Pulmonary 
embolism, postoperative) 
• “complkey” = 14 
(DVT/ 
thrombophlebitis) 






• 410.X (Acute myocardial 
infarction) 
• “ncdmi” (Myocardial 
infarction, postoperative) 
• “complkey” = 18 
(Myocardial infarction) 
Pneumonia • 480-486 
• (Pneumonia/ 
Bronchopneumonia) 
• “noupneumo” (Pneumonia, 
postoperative) 




• 998.5X (Postoperative 
infection, not elsewhere 
classified) 
• 998.67 (Infection and 
inflammatory reaction 
due to other internal 
orthopedic device, 
implant, or graft) 
• “nsupinfec” (Superficial 
SSI, postoperative) 
• “nwndinfd” (Deep SSI, 
postoperative) 
 




• “complkey” = 12 (Deep 
SSI) 
• “complkey” = 19 
(Organ/space SSI) 




• 599.0 (Urinary tract 
infection) 
• “nurninfec” (Urinary tract 
infection, postoperative) 
• “complkey” = 27 
(Urinary tract infection) 
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